RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Content

Kuzin Alexander Vladimirovich
Kuzin Alexander Vladimirovich

Biography

2004-2009

From 2004 to 2009 headed DSM Group – one of the largest analytical agencies on pharmaceutical market of Russia.

In 2006 became the member of coordination council of the Russian Association of Pharmaceutical Marketing (RAPM)

2015-2019

In 2015 Alexander Kuzin became the managing director of RMI Partners which directs Rosnanomedinvest venture fund

In 2017 it is appointed the CEO of Novamedika company. Under the leadership of Kuzin Novamedika started creation of own medicines, opened R&D-центр, construction of the plant in the Kaluga region became the strategic partner of Pfizer and within this partnership of the beginning.

In 2018 Alexander Kuzin was included into Expert advice of the Russian State Duma Committee on health protection.

In 2019 headed the retail direction of Drugstore 36.6 network.

2020: Position assignment of the CEO of "Pharmacy chain 36.6"

In October, 2020 Alexander Kuzin headed PJSC Pharmacy Chain 36.6 instead of Vladimir Nesterenko. The Board of Directors of the company made the relevant decision on October 22, and official change of the CEO happened next day.

File:Aquote1.png
The strong head, one of the best specialists in a pharmroznitsa in Russia who has behind shoulders a work in Rigla and Novamedika joined the 36.6 command. I do not doubt that Alexander Kuzin will strengthen the company and together we will bring "36.6 pharmacy chain to new level — Vladimir Nesterenko commented on appointment.
File:Aquote2.png

Nesterenko also said that he will remain in Board of Directors of PJSC 36.6 Pharmacy Chain and will develop the new directions, including distribution. He held a position of the CEO of all group in 2018, after Polina Kiselyova's leaving.

Earlier in October, 2020 the direction, new to the company, according to transactions M&A was headed by Miroslav Zakusilov who was earlier engaged M&A in Rigla and organic development in X5 Retail Group. Alexander Kurilov taking similar positions in the pharmaceutical companies entering into AFK "Sistema" holding is appointed the chief financial officer. To Kurilov on this post there was Vladimir Kondratyev.

Notes